In a preclinical study, a new CAR T-cell strategy was very successful against small cell lung cancer.

Published Date: 26 Apr 2023

In a preclinical study, a novel method of CAR T-cell therapy against small cell lung cancer (SCLC) has shown great promise. Our knowledge of CAR T has been expanded by the findings.

Read Full News

Latest News

Eye Inflammation Tied to Anti-Adalimumab Antibody Formation

Patients with autoimmune diseases who experience ocular inflammation while on adalimumab have an increased risk of developing antibodies against the drug, according to a recent retrospective study.

Ralinepag Offers Once Daily Oral Option for PAH

Phase 3 data provide the foundation for a planned New Drug Application.

WHO Chief Says Fast-moving Ebola Epidemic Is Outpacing Response Efforts

The head of the World Health Organization said on Monday that the ⁠fast-moving Ebola outbreak in Democratic Republic of Congo and Uganda was outpacing response ⁠efforts,...

Suspected and Confirmed Measles Deaths Top 500 in Bangladesh

It's one of the country's worst outbreaks in decades.

Experimental Treatments Could Help US Ebola Patient

The U.S. missionary who tested positive for Ebola and is undergoing treatment in a German hospital has been given drugs aimed at reducing disease symptoms after exposure to...

Pill for Obstructive Sleep Apnea Shows Potential

AD109 works by targeting neuromuscular dysfunction of upper airway muscles during sleep, representing a potential new strategy to help people with obstructive sleep apnea.

Todays Updates

Psychotropics Linked to Increased BMI, CVD Risk

Psychotropics are associated with increased BMI, and users with a high BMI genetic risk score and an unhealthy lifestyle have triple the risk for CVD, new research shows.

Tafasitamab Combo Boosts R-CHOP in Frontline DLBCL

Tafasitamab and lenalidomide are likely to be approved with R-CHOP for frontline DLBCL, but with bispecific antibodies on the horizon, the role of the combination is uncertain.

Abemaciclib Slows Progression of Advanced Liposarcoma

In a phase 3 trial of patients with dedifferentiated liposarcoma, the CDK4/6 inhibitor extended progression-free survival more than sixfold.

Therapy Combo Improves Radiographic PFS in Prostate Cancer

A phase 3 trial evaluates a PARP inhibitor or placebo plus an androgen pathway inhibitor to treat men with advanced prostate cancer associated with genetic changes.

Teclistamab Alone Ups Previously Treated Myeloma Survival

In the first phase 3 trial of teclistamab monotherapy, the bispecific antibody was associated with better PFS and OS than standard regimens in relapsed or refractory multiple myeloma.

Trial Supports Ivonescimab and Chemo for NSCLC Survival

A phase 3 trial evaluates the safety and efficacy of an investigational bispecific antibody with chemotherapy compared to standard treatment in advanced squamous NSCLC.

Asandeutertinib Tops Osimertinib for NSCLC With Brain Mets

In an interim analysis of a randomized phase 2 trial, asandeutertinib improved intracranial response and intracranial PFS vs osimertinib in patients with EGFR-mutated NSCLC with brain metastases.

Todays Updates

Psychotropics Linked to Increased BMI, CVD Risk

Psychotropics are associated with increased BMI, and users with a high BMI genetic risk score and an unhealthy lifestyle have triple the risk for CVD, new research shows.

Tafasitamab Combo Boosts R-CHOP in Frontline DLBCL

Tafasitamab and lenalidomide are likely to be approved with R-CHOP for frontline DLBCL, but with bispecific antibodies on the horizon, the role of the combination is uncertain.

Abemaciclib Slows Progression of Advanced Liposarcoma

In a phase 3 trial of patients with dedifferentiated liposarcoma, the CDK4/6 inhibitor extended progression-free survival more than sixfold.

Therapy Combo Improves Radiographic PFS in Prostate Cancer

A phase 3 trial evaluates a PARP inhibitor or placebo plus an androgen pathway inhibitor to treat men with advanced prostate cancer associated with genetic changes.

Teclistamab Alone Ups Previously Treated Myeloma Survival

In the first phase 3 trial of teclistamab monotherapy, the bispecific antibody was associated with better PFS and OS than standard regimens in relapsed or refractory multiple myeloma.

Trial Supports Ivonescimab and Chemo for NSCLC Survival

A phase 3 trial evaluates the safety and efficacy of an investigational bispecific antibody with chemotherapy compared to standard treatment in advanced squamous NSCLC.

Asandeutertinib Tops Osimertinib for NSCLC With Brain Mets

In an interim analysis of a randomized phase 2 trial, asandeutertinib improved intracranial response and intracranial PFS vs osimertinib in patients with EGFR-mutated NSCLC with brain metastases.

Latest News

Patients with autoimmune diseases who experience ocular inflammation while on adalimumab have an increased risk of developing antibodies against the drug, according to a recent retrospective study.

Phase 3 data provide the foundation for a planned New Drug Application.

The head of the World Health Organization said on Monday that the ⁠fast-moving Ebola outbreak in Democratic Republic of Congo and Uganda was outpacing response ⁠efforts,...

It's one of the country's worst outbreaks in decades.

The U.S. missionary who tested positive for Ebola and is undergoing treatment in a German hospital has been given drugs aimed at reducing disease symptoms after exposure to...

AD109 works by targeting neuromuscular dysfunction of upper airway muscles during sleep, representing a potential new strategy to help people with obstructive sleep apnea.

News All Time

Treprostinil Turns Heads in Promising IPF Study

Data from the TETON-1 phase 3 trial showed even greater response over TETON-2 study.

Ketamine Tied to Rapid Relief of Depression Symptoms

A meta-analysis links intravenous ketamine with significant reductions in suicidal thoughts and depressive symptoms within hours of treatment.

Talking Bot Wins Over Patients and Docs in Ophthalmology

A voice-based generative AI assistant designed for patient education in ophthalmology is well received by patients, healthcare professionals, and practice managers, according to a qualitative study.

CDC Offers Hantavirus Guidance, Says Risk Is Extremely Low

Forty-one Americans considered at higher risk are being monitored, while public health labs scramble to validate PCR assays that can detect infection before symptoms start.

ECMO Cannulation Improves Outcomes as Lung Transplant Bridge

Clinical advantage was notable in older patients.

'Deadly Mix' Puts Patients at Risk, RCN Congress Hears

A quarter of nurses say staffing on their last shift was so far below what was needed that patients and staff faced a high risk of harm, an RCN survey shows.

Flawed Tests and Funerals Allowed Ebola to Spread Undetected, Sources Say

By the time health officials confirmed new Ebola infections in eastern Democratic Republic of Congo last week, the total number of suspected cases meant the outbreak was...

American Doctor Has Ebola, Will Be Transferred for Care

Two other physicians — including the doctor’s wife — were potentially exposed, along with their four children.

FDA Psychiatry Roundup: April 2026

A monthly snapshot of FDA activity involving therapies used in the prevention and treatment of psychiatric conditions.

Is Ketamine for Depression Moving Too Fast on Weak Data?

Ketamine has been hailed as a fast-acting, effective treatment for major depression. But new research questions whether the drug lives up to its hype.

IA Thrombolysis After Thrombectomy: More Uncertainty

The TECNO trial finds no clear reperfusion benefit from intra-arterial thrombolysis after thrombectomy in acute ischemic stroke, raising fresh doubts about the strategy.

Aging in Hospital Medicine: How to Retain Older Hospitalists

The schedule and demanding nature of the job make hospitalist jobs more difficult as you age. Some systems are trying to help.

Soccer-Study Warns Of Dangerous Heat At 2026 World Cup as Climate Risks Grow

Football's global players' union renewed concerns on Thursday about heat at the 2026 World Cup after scientists warned the likelihood of dangerous temperatures for players...

Is Flare Prophylaxis Always Needed When Starting Gout Drugs?

There are divided opinions over whether anti-inflammatory drugs should always be used when initiating urate-lowering therapy for gout. Would a ‘pill in the pocket’ approach be better?

CMV Infection in Early Pregnancy Tied to Autism Risk in Kids

Children with congenital cytomegalovirus infection may experience complications such as autism and hearing loss if their mothers have a first-time infection during the first trimester.

Medicine Through Film: 10 Classics for Clinicians

Ten cinematic classics trace medicine’s moral, social, and scientific dilemmas — a curated watchlist that highlights storytelling, stigma, and a call for female leads.

Recommended News For You

'Full House' Star's Cancer; Fluoride Fears Go Mainstream; Florida Doctor Arrested

'Sleep ALL night' program helps children with leukemia sleep better during treatment

A Possible Novel CAR-T Treatment for High-Risk R/R Follicular Lymphoma May Be Liso-Cel.

A Chemo-Free Option for Some Advanced Endometrial Cancers?

These Athletes Weren't Doping. Their Genes Made It Look Like They Did.

Study recommends new grading system for invasive squamous cell carcinoma of the lung

Olaparib-Abiraterone in mCRPCs Selected by Biomarkers Outperforms Each Agent by Itself.

Recommended Articles For You

A New Perspective on Spherocytosis: Uncovering Innovative Treatments 

Surgery for Tracheoesophageal Fistula: What to Expect Before, During, and After  

Unlocking the Potential of Immune Checkpoint Inhibitors: A Pioneering Case Series on the Role of Immunotherapy in Microsatellite-Instability-High Colorectal Cancer 

Unlocking the Potential of Etoposide: A Novel Approach to Cancer Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Adult overdose deaths on the rise

2.

What Role Should Genomic Classifier Testing Play in Prostate Cancer?

3.

To automate the biopharmaceutical facilities of Reliance Life Sciences, ABB India has won the contract.

4.

Cancer tumor anatomy influences the benefits of chemotherapy for patients with early-stage breast cancer.

5.

New study links air pollution with higher rates of head and neck cancer

1.

Liquid Biopsy in Oncology: Innovations in Cancer Detection, Monitoring, and Clinical Use

2.

Essential Oncology Tools: Risk Assessment, Telehealth, AI, and Monitoring

3.

The Importance of Maintaining Normal Calcium Levels in Your Body 

4.

The Truth About Marijuana and Its Effect on Mental Health 

5.

Mastering Modern Oncology: Accreditation, Education, and Research Trends for 2025

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Efficient Management of First line ALK-rearranged NSCLC - Part II

2.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion

3.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC

4.

Exploring the Hospitalization Burden in Refractory and Relapsed ALL

5.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot